Shire is reportedly looking at buying U.S.-based NPS Pharmaceuticals.
Shire is reportedly looking at buying U.S.-based NPS Pharmaceuticals.
The news comes just a couple of months after AbbVie dropped its takeover offer for Shire.
Shire received a US$1.64-billion breakup fee after that deal collapsed.
NPS Pharmaceuticals’ current therapeutic areas of focus are gastrointestinal disease and endocrine disorders.
For the full story, visit the Bloomberg News website.
Read:
On June 6, Benefits Canada hosted its annual Mental Health Summit, the industry’s most popular and well-known conference in this space. Designed for employers and the advisors...
While self-management strategies for mental health can empower plan members, plan sponsors also have a role to play in creating a work environment that’s conducive...
People leaders and managers have an important role to play in the well-being of their team members, said Carmen Bellows, registered psychologist and director of...
It’s important for plan sponsors to educate employees about the benefits of a good night’s sleep, said Ken Porter, national sustainability director for the Mood...
More than a third (36 per cent) of Canadian workers have been bothered by thoughts of death or self-harm over the past year, according to a...
During a panel at the Canadian Investment Review’s 2024 Global Investment Conference in April, three key thought leaders representing defined benefit pension plan sponsors shared...
Retirement plan members who engage with their plan digitally have an average retirement account balance 230 per cent higher than those who weren’t engaged ($123,800 versus $51,800), according to...
Nearly half (49 per cent) of executive leaders say financial stress often or very often prevents their frontline workers from doing their best work, according to...